STAT China: Big news at Simcere, and a breakthrough designation for Legend Biotech
China endorses an ambitious CAR-T project, and another biotech company is reportedly mulling a Hong Kong IPO later this year.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario